Physicians' ability to predict the risk of coronary heart disease
- PMID: 12857356
- PMCID: PMC183837
- DOI: 10.1186/1472-6963-3-13
Physicians' ability to predict the risk of coronary heart disease
Abstract
Background: Coronary heart disease (CHD) is the leading cause of death in the United States. Previous research examining physicians ability to estimate cardiovascular risk has shown that physicians' generally overestimate the absolute risk of CHD events. This question has, however, only studied risk prediction for a limited number of patient care scenarios. The aim of this study is to measure the ability of physicians to estimate the risk of CHD events in patients with no previous history of coronary heart disease.
Methods: Twelve primary prevention scenarios with a 5-year risk of CHD events were developed. This questionnaire was surveyed at 3 university teaching hospitals where the participants were a convenience sample of internal medicine residents and fellows or attending physicians in general internal medicine or cardiology. For each scenario, physicians were asked to estimate the baseline 5-year risk of a coronary heart disease event and the revised risk if the patient were to receive lipid-lowering drug therapy. Estimates of the baseline 5-year risk were compared with values calculated from Framingham risk equations. Inaccurate responses were defined as those with a ratio of estimated to actual risk of more than 1.5 or less than 0.67. Physicians' estimates of the relative risk reduction with therapy were considered to be accurate if they were between 25% and 40%.
Results: 79 physicians (53 residents, 8 fellows, 18 attending physicians) completed the survey. Only 24% of physicians' risk estimates were accurate. In most cases, physicians overestimated the absolute risk of cardiovascular events without therapy (proportion overestimating ranged from 32-92% for the 12 individual scenarios). Physicians made larger errors in patient scenarios involving patients with high total or LDL cholesterol levels. Physicians' estimates of the relative risk reduction from treatment were more accurate: 43% of estimates were between 25 and 40%. Over 85% of physicians recommended treatment in 10 of 12 scenarios.
Conclusions: Physicians overestimate the absolute risk of CHD events and the potential absolute benefit of drug therapy.
Similar articles
-
A survey of physicians show a one-third reduction in harmful outcomes to be a clinically important difference for statin therapy.J Clin Epidemiol. 2012 Sep;65(9):954-61. doi: 10.1016/j.jclinepi.2012.02.019. Epub 2012 Jun 27. J Clin Epidemiol. 2012. PMID: 22742918
-
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.N Engl J Med. 2005 Apr 7;352(14):1425-35. doi: 10.1056/NEJMoa050461. Epub 2005 Mar 8. N Engl J Med. 2005. PMID: 15755765 Clinical Trial.
-
[Statins in primary prevention of coronary heart disease].Wien Med Wochenschr. 1999;149(5-6):129-38. Wien Med Wochenschr. 1999. PMID: 10408004 Review. German.
-
Attitude changes of general practitioners towards lowering LDL cholesterol.J Cardiovasc Risk. 1998 Feb;5(1):43-6. J Cardiovasc Risk. 1998. PMID: 9816555
-
Cholesterol: precursor to many lipid disorders.Am J Manag Care. 2001 Aug;7(9 Suppl):S289-98. Am J Manag Care. 2001. PMID: 11517815 Review.
Cited by
-
Perceptions of risk: understanding cardiovascular disease.Risk Manag Healthc Policy. 2010;3:49-60. doi: 10.2147/RMHP.S8288. Epub 2010 Sep 6. Risk Manag Healthc Policy. 2010. PMID: 22312218 Free PMC article.
-
Risk scoring for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2017 Mar 14;3(3):CD006887. doi: 10.1002/14651858.CD006887.pub4. Cochrane Database Syst Rev. 2017. PMID: 28290160 Free PMC article.
-
Adding a life-course perspective to cardiovascular-risk communication.Nat Rev Cardiol. 2013 Feb;10(2):111-5. doi: 10.1038/nrcardio.2012.185. Epub 2013 Jan 8. Nat Rev Cardiol. 2013. PMID: 23296067 Review.
-
Assessing coronary risk assessment: what's next?J Gen Intern Med. 2010 Nov;25(11):1140-1. doi: 10.1007/s11606-010-1469-8. J Gen Intern Med. 2010. PMID: 20697964 Free PMC article. No abstract available.
-
Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges.J Pharm Bioallied Sci. 2017 Apr-Jun;9(2):80-87. doi: 10.4103/jpbs.JPBS_30_17. J Pharm Bioallied Sci. 2017. PMID: 28717329 Free PMC article. Review.
References
-
- Hoyert DL, Kochanek KD, Murphy SL. Deaths: final data for 1997. Natl Vital Stat Rep. 1999;47:1–104. - PubMed
-
- American Heart Association 2002 Heart and Stroke Statistical Update. 30
-
- The health benefits of smoking cessation: a report of the Surgeon General. Rockville, US Department of Health and Human Services, Public Health Service, and Centers for Disease Control.